COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 3 of 3 for:    me-344

ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02806817
Recruitment Status : Completed
First Posted : June 21, 2016
Last Update Posted : July 23, 2019
Fundacion CRIS de Investigación para Vencer el Cáncer
Information provided by (Responsible Party):
Centro Nacional de Investigaciones Oncologicas CARLOS III

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2018
Actual Study Completion Date : November 2018